GlassScriptPhysician profile
Eric J Homberg
NPI 1548304835
$16,363.65
in general payments reported to CMS, 2019-2025
39 companies · $3,021 in 2025
The $3,021 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,829 · 2020: $388 · 2021: $849 · 2022: $1,653 · 2023: $2,243 · 2024: $3,380 · 2025: $3,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,392 · Travel and Lodging: $3,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,392.19 |
| Travel and Lodging | $3,252.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,488.09 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Freelink |
| Medtronic, INC. | $2,605.49 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Nalu Medical, INC. | $2,293.67 | 2021-2025 | Nalu Neurostimulation System |
| Vertiflex, INC. | $1,589.68 | 2019 | |
| Stryker Corporation | $1,044.23 | 2025 | Spinejack, Mild Device Kit |
| Amgen INC. | $669.07 | 2020-2025 | Evenity, Prolia |
| Spr Therapeutics, INC | $636.28 | 2025 | Sprint Pns System |
| Abbott Laboratories | $472.90 | 2023-2024 | Proclaim, Prodigy, Eterna |
| Tersera Therapeutics LLC | $285.06 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $220.55 | 2020-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $199.79 | 2021-2023 | Ztlido |
| Collegium Pharmaceutical, INC. | $193.00 | 2020-2025 | Belbuca |
| Stimwave Technologies Incorporated | $184.02 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $181.72 | 2019-2020 | |
| Vertos Medical, INC. | $165.52 | 2019-2024 | Mild Device Kit |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Flowonix Medical Incorporated | $150.25 | 2019 | |
| Azurity Pharmaceuticals, INC. | $115.80 | 2023-2024 | Horizant, Horizant |
| Pfizer INC. | $96.55 | 2019-2021 | |
| Painteq LLC | $95.64 | 2022-2024 | Painteq |
| Vertex Pharmaceuticals Incorporated | $74.03 | 2025 | |
| Averitas Pharma INC. | $72.60 | 2023-2025 | Qutenza |
| Pacira Therapeutics, INC. | $62.54 | 2019 | |
| Lilly USA, LLC | $51.45 | 2019-2021 | |
| Gentleman Orthopedic Solutions | $51.14 | 2019 | |
| Globus Medical, INC. | $49.59 | 2025 | Vyrsa V1 |
| Curonix LLC | $35.61 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Supernus Pharmaceuticals, INC. | $35.42 | 2019 | |
| Grt US Holding, INC. | $33.57 | 2022 | |
| Biodelivery Sciences International, INC. | $30.03 | 2020-2021 | |
| Kaleo, INC. | $26.41 | 2019 | |
| Radius Health, INC. | $25.63 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $23.72 | 2024 | Exparel, Iovera, Zilretta |
| Nevro Corp. | $20.22 | 2019 | |
| Biotronik Nro, INC. | $16.81 | 2025 | Prospera |
| Assertio Therapeutics, INC. | $15.62 | 2020 | |
| Medtronic USA, INC. | $14.16 | 2019 | |
| Abbvie INC. | $13.69 | 2024 | |
| Virtus Pharmaceuticals LLC | $12.13 | 2021 | |
| Orthofix Medical, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Homberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.